1. Home
  2. PVLA vs FSTR Comparison

PVLA vs FSTR Comparison

Compare PVLA & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • FSTR
  • Stock Information
  • Founded
  • PVLA 2015
  • FSTR 1902
  • Country
  • PVLA United States
  • FSTR United States
  • Employees
  • PVLA N/A
  • FSTR N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • FSTR Metal Fabrications
  • Sector
  • PVLA Health Care
  • FSTR Industrials
  • Exchange
  • PVLA Nasdaq
  • FSTR Nasdaq
  • Market Cap
  • PVLA 285.2M
  • FSTR 239.1M
  • IPO Year
  • PVLA N/A
  • FSTR N/A
  • Fundamental
  • Price
  • PVLA $56.84
  • FSTR $27.43
  • Analyst Decision
  • PVLA Strong Buy
  • FSTR Hold
  • Analyst Count
  • PVLA 12
  • FSTR 1
  • Target Price
  • PVLA $59.00
  • FSTR $25.00
  • AVG Volume (30 Days)
  • PVLA 123.6K
  • FSTR 32.9K
  • Earning Date
  • PVLA 08-14-2025
  • FSTR 11-06-2025
  • Dividend Yield
  • PVLA N/A
  • FSTR N/A
  • EPS Growth
  • PVLA N/A
  • FSTR 395.33
  • EPS
  • PVLA N/A
  • FSTR 3.32
  • Revenue
  • PVLA N/A
  • FSTR $506,999,000.00
  • Revenue This Year
  • PVLA N/A
  • FSTR $4.25
  • Revenue Next Year
  • PVLA N/A
  • FSTR $3.61
  • P/E Ratio
  • PVLA N/A
  • FSTR $8.23
  • Revenue Growth
  • PVLA N/A
  • FSTR N/A
  • 52 Week Low
  • PVLA $11.17
  • FSTR $17.16
  • 52 Week High
  • PVLA $61.48
  • FSTR $29.78
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 64.06
  • FSTR 64.40
  • Support Level
  • PVLA $49.81
  • FSTR $25.70
  • Resistance Level
  • PVLA $61.48
  • FSTR $27.37
  • Average True Range (ATR)
  • PVLA 4.43
  • FSTR 0.95
  • MACD
  • PVLA -0.19
  • FSTR 0.13
  • Stochastic Oscillator
  • PVLA 62.41
  • FSTR 93.47

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About FSTR L.B. Foster Company

L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

Share on Social Networks: